银屑病、心血管疾病与脂肪因子
Psoriasis,Cardiovascular Disease,and Adipokines
查看参考文献40篇
|
文摘
|
银屑病常合并代谢性疾病,且银屑病患者心血管疾病患病率明显升高。研究显示在代谢性疾病中发挥重要作用的脂肪因子在心血管疾病及银屑病患者中也存在表达水平的异常,脂肪因子可能在诱发加重银屑病及心血管疾病中扮演重要角色,是银屑病与心血管疾病相互影响的原因之一。研究表明与银屑病及心血管疾病相关的脂肪因子包括脂联素、瘦素、抵抗素、网膜素、内脂素、趋化素及视黄醇结合蛋白4等。其中脂联素、网膜素在银屑病患者中的水平较正常对照者下降,可能在银屑病中充当保护角色。同样,脂联素在心血管疾病中充当保护角色,而网膜素在心血管疾病中的作用尚有争议。瘦素、抵抗素、内脂素、趋化素及视黄醇结合蛋白4在银屑病及心血管疾病患者中较正常对照者升高,可能是银屑病及心血管疾病的致病因素,其中脂联素缺乏、瘦素、内脂素、趋化素已在体外实验或动物模型中证实可通过激活浆细胞样树突状细胞、T细胞等而诱发加重银屑病。但内脂素在体外实验中对心肌细胞发挥抗凋亡的保护作用。 |
|
其他语种文摘
|
Psoriasis usually combines with metabolic diseases,and the prevalence of cardiovascular disease remarkably increases in psoriatic patients.Adipokines,which play an important role in the cardiovascular diseases,also express abnormally in psoriasis and may induce or exacerbate the skin lesion.The adipokines associated with psoriasis and cardiovascular disease include adiponectin,leptin,resistin,omentin,visfatin,chemerin,and retinoid binding protein 4 (RBP-4).The levels of adiponectin and omentin apparently decrease in psoriatic patients compared to healthy controls,and thus they may play protective roles for psoriasis.Similarly,adiponectin plays a protective role in cardiovascular disease,but the role of retina in cardiovascular disease is still controversial.However,the concentrations of leptin,resistin,visfatin,chemerin,and RBP-4 in patients with psoriasis or cardiovascular disease are significantly higher than those of the controls;therefore,they may serve as the pathogenic factors for both diseases.Low adiponectin,leptin,visfatin,and chemerin levels may induce or aggravate psoriasis by activating plasmacytoid dendritic cells or T cells,as demonstrated in in vitro experiments.However,in vitro experiments also have shown that visfatin may inhibit cardiomyocyte apoptosis. |
|
来源
|
中国医学科学院学报
,2018,40(4):556-562 【核心库】
|
|
DOI
|
10.3881/j.issn.1000-503x.9793
|
|
关键词
|
银屑病
;
心血管疾病
;
脂肪因子
|
|
地址
|
中国医学科学院北京协和医学院北京协和医院皮肤科, 北京, 100730
|
|
语种
|
中文 |
|
文献类型
|
综述型 |
|
ISSN
|
1000-503X |
|
学科
|
皮肤病学与性病学 |
|
基金
|
北京市自然科学基金
|
|
文献收藏号
|
CSCD:6321422
|
参考文献 共
40
共2页
|
|
1.
Coumbe A G. Cardiovascular risk and psoriasis:beyond the traditional risk factors.
Am J Med,2014,127(1):12-18
|
CSCD被引
4
次
|
|
|
|
|
2.
Eder L. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
Ann Rheum Dis,2013,72(12):1956-1961
|
CSCD被引
4
次
|
|
|
|
|
3.
Li R C. Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors.
Clin Exp Dermatol,2014,39(1):19-24
|
CSCD被引
2
次
|
|
|
|
|
4.
Kaur S. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis.
J Eur Acad Dermatol Venereol,2011,25(11):1328-1333
|
CSCD被引
2
次
|
|
|
|
|
5.
Shibata S. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.
Nat Commun,2015,6(15):7687
|
CSCD被引
12
次
|
|
|
|
|
6.
Lindberg S. Adiponectin,type 2 diabetes and cardiovascular risk.
Eur J Prev Cardiol,2015,22(3):276-283
|
CSCD被引
5
次
|
|
|
|
|
7.
Herder C. Adiponectin and bariatric surgery:associations with diabetes and cardiovascular disease in the Swedish Obese Subjects Study.
Diabetes Care,2014,37(5):1401-1409
|
CSCD被引
1
次
|
|
|
|
|
8.
Persson J. Sex-specific effects of adiponectin on carotid intima-media thickness and incident cardiovascular disease.
J Am Heart Assoc,2015,4(8):e001853
|
CSCD被引
1
次
|
|
|
|
|
9.
Oh Y. Serum leptin and adiponectin levels in Korean patients with psoriasis.
J Korean Med Sci,2014,29(5):729-734
|
CSCD被引
1
次
|
|
|
|
|
10.
Baran A. Effect of psoriasis activity on serum adiponectin and leptin levels.
Postepy Dermatol Alergol,2015,32(2):101-106
|
CSCD被引
5
次
|
|
|
|
|
11.
Xue K. Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro-a possible reason for increased severity of psoriasis in patients with a high body mass index.
Exp Dermatol,2013,22(6):406-410
|
CSCD被引
4
次
|
|
|
|
|
12.
Takahashi H. Prevalence of obesity/adiposity in Japanese psoriasis patients:adiposity is correlated with the severity of psoriasis.
J Dermatol Sci,2009,55(1):74-76
|
CSCD被引
1
次
|
|
|
|
|
13.
Bidulescu A. Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans:the jackson heart study.
Front Public Health,2013,1:16
|
CSCD被引
3
次
|
|
|
|
|
14.
Korolczuk A. Increased risk of cardiovascular complications in chronic kidney disease:a possible role of leptin.
Curr Pharm Des,2014,20(4):666-674
|
CSCD被引
4
次
|
|
|
|
|
15.
Takahashi H. Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.
Arch Dermatol Res,2013,305(2):113-116
|
CSCD被引
1
次
|
|
|
|
|
16.
Robati R. Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis:is psoriasis associated with atherosclerosis?.
J Am Acad Dermatol,2014,71(4):642-648
|
CSCD被引
2
次
|
|
|
|
|
17.
Pina T. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
J Eur Acad Dermatol Venereol,2015,29(10):1995-2001
|
CSCD被引
2
次
|
|
|
|
|
18.
Joksic J. Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery disease.
Biochem Med (Zagreb),2015,25(2):242-251
|
CSCD被引
2
次
|
|
|
|
|
19.
Sinan U Y. Relationship between increased serum resistin level and severity of coronary artery disease.
Angiology,2014,65(3):239-242
|
CSCD被引
3
次
|
|
|
|
|
20.
Menzaghi C. Serum resistin,cardiovascular disease and all-cause mortality in patients with type 2 diabetes.
PLoS One,2014,8(6):e64729
|
CSCD被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问